SCHEMBL26313167

SCHEMBL26313167

COc1ccc(Cn2cc(-c3cc(C(F)F)nc(Sc4cccc(NC(=O)OC(C)(C)C)c4)n3)ccc2=O)cc1OC

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SDHB P21912 11/20 0.44
▸ MKNK1 Q9BUB5 2/20 0.39
▸ MKNK2 Q9HBH9 2/20 0.39
▸ MAPT P10636 3/20 0.38
▸ TP53 P04637 1/20 0.38
▸ STAT3 P40763 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ AKR1C3 P42330 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.35
▸ P2RX3 P56373 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26313170 0.92 MKNK1 (0.46) SDHBMKNK1MKNK2MAPTTP53
SCHEMBL26313160 0.85 SDHB (0.43) SDHBMKNK1MKNK2MAPTTP53
SCHEMBL26313158 0.85 SDHB (0.52) SDHBMKNK1MKNK2
SCHEMBL26313164 0.84 SDHB (0.49) SDHBMKNK1MKNK2MAPTTP53
SCHEMBL26313146 0.84 SDHB (0.49) SDHBMAPTTP53MEN1KMT2A
SCHEMBL19805843 0.79 SDHB (0.55) SDHBMAPTTP53SMN1; SMN2
SCHEMBL19805988 0.77 SDHB (0.53) SDHBMAPTTP53SMN1; SMN2ALDH1A1
SCHEMBL20985710 0.76 SDHB (0.54) SDHBMKNK1MKNK2MAPTSMN1; SMN2
SCHEMBL19806088 0.75 SDHB (0.54) SDHBMAPTTP53
SCHEMBL26313143 0.74 SDHB (0.57) SDHBMAPTTP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11725000-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2023-08-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11725000-B2 Apoptosis inhibitors BAX, SDHA, SDHB SDHB 3/4885MKNK1 1954/4885MKNK2 2039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback